Cognition Therapeutics To Be Issued US Patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"
Cognition Therapeutics To Be Issued US Patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"
Cognition Therapeutics將頒發美國專利號11,981,636，標題爲 “用於治療神經退行性疾病（包括阿爾茨海默氏病和認知衰退）的組合物”
Cognition Therapeutics To Be Issued US Patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"
Cognition Therapeutics將頒發美國專利號11,981,636，標題爲 “用於治療神經退行性疾病（包括阿爾茨海默氏病和認知衰退）的組合物”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間